{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:54:17Z","timestamp":1793307257947,"version":"4.5.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/nrgastro.2015.94","type":"journal-article","created":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T10:11:43Z","timestamp":1433844703000},"page":"387-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":557,"title":["Inflammasome activation and function in liver disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Gyongyi","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Petrasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"BFnrgastro201594_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54","author":"CA Janeway Jr","year":"1989","unstructured":"Janeway, C. A., Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1\u201313 (1989).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BFnrgastro201594_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991\u20131045 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrgastro201594_CR3","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI43132","volume":"120","author":"Y Shi","year":"2010","unstructured":"Shi, Y. Caught red-handed: uric acid is an agent of inflammation. J. Clin. Invest. 120, 1809\u20131811 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322\u2013335 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.26494","volume":"59","author":"B Chassaing","year":"2014","unstructured":"Chassaing, B., Etienne-Mesmin, L. & Gewirtz, A. T. Microbiota-liver axis in hepatic disease. Hepatology 59, 328\u2013339 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR6","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","volume":"130","author":"RF Schwabe","year":"2006","unstructured":"Schwabe, R. F., Seki, E. & Brenner, D. A. Toll-like receptor signaling in the liver. Gastroenterology 130, 1886\u20131900 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR7","doi-asserted-by":"publisher","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","volume":"300","author":"B Gao","year":"2011","unstructured":"Gao, B. et al. Innate immunity in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G516\u2013G525 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201594_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.21308","volume":"44","author":"G Szabo","year":"2006","unstructured":"Szabo, G., Dolganiuc, A. & Mandrekar, P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44, 287\u2013298 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","volume":"143","author":"P Kubes","year":"2012","unstructured":"Kubes, P. & Mehal, W. Z. Sterile inflammation in the liver. Gastroenterology 143, 1158\u20131172 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826\u2013837 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201594_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.4049\/jimmunol.1000724","volume":"185","author":"SE Warren","year":"2010","unstructured":"Warren, S. E. et al. Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2. J. Immunol. 185, 818\u2013821 (2010).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2006.08.002","volume":"126","author":"Y Ogura","year":"2006","unstructured":"Ogura, Y., Sutterwala, F. S. & Flavell, R. A. The inflammasome: first line of the immune response to cell stress. Cell 126, 659\u2013662 (2006).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","volume":"57","author":"G Szabo","year":"2012","unstructured":"Szabo, G. & Csak, T. Inflammasomes in liver diseases. J. Hepatol. 57, 642\u2013654 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrgastro201594_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/08830185.2010.529976","volume":"30","author":"H Kumar","year":"2011","unstructured":"Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16\u201334 (2011).","journal-title":"Int. Rev. Immunol."},{"key":"BFnrgastro201594_CR17","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.24599","volume":"54","author":"P Mandrekar","year":"2011","unstructured":"Mandrekar, P., Ambade, A., Lim, A., Szabo, G. & Catalano, D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54, 2185\u20132197 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR18","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476\u20133489 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice. Gastroenterology 139, 323\u2013334 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228\u2013232 (2006).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","volume":"9","author":"KL Rock","year":"2013","unstructured":"Rock, K. L., Kataoka, H. & Lai, J. J. Uric acid as a danger signal in gout and its comorbidities. Nat. Rev. Rheumatol. 9, 13\u201323 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrgastro201594_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133\u2013144 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR23","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/hep.25932","volume":"56","author":"T Matsuzaka","year":"2012","unstructured":"Matsuzaka, T. et al. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56, 2199\u20132208 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408\u2013415 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179\u2013188 (2011).","journal-title":"Nat. Med."},{"key":"BFnrgastro201594_CR26","doi-asserted-by":"publisher","first-page":"26213","DOI":"10.1074\/jbc.M114.580175","volume":"289","author":"N Shulga","year":"2014","unstructured":"Shulga, N. & Pastorino, J. G. Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure. J. Biol. Chem. 289, 26213\u201326225 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201594_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1053\/j.gastro.2010.08.020","volume":"140","author":"J Petrasek","year":"2011","unstructured":"Petrasek, J., Dolganiuc, A., Csak, T., Kurt-Jones, E. A. & Szabo, G. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology 140, 697\u2013708.e4 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR28","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood.V79.9.2364.2364","volume":"79","author":"EV Granowitz","year":"1992","unstructured":"Granowitz, E. V., Vannier, E., Poutsiaka, D. D. & Dinarello, C. A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79, 2364\u20132369 (1992).","journal-title":"Blood"},{"key":"BFnrgastro201594_CR29","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1182\/blood.V79.9.2356.2356","volume":"79","author":"EV Granowitz","year":"1992","unstructured":"Granowitz, E. V., Clark, B. D., Vannier, E., Callahan, M. V. & Dinarello, C. A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 79, 2356\u20132363 (1992).","journal-title":"Blood"},{"key":"BFnrgastro201594_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519\u2013550 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrgastro201594_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1055\/s-0030-1255352","volume":"30","author":"W Mehal","year":"2010","unstructured":"Mehal, W. & Imaeda, A. Cell death and fibrogenesis. Semin. Liver Dis. 30, 226\u2013231 (2010).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro201594_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hep.22335","volume":"48","author":"BD Cosgrove","year":"2008","unstructured":"Cosgrove, B. D. et al. An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-\u03b1. Hepatology 48, 276\u2013288 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200009073431011","volume":"343","author":"CA Dinarello","year":"2000","unstructured":"Dinarello, C. A. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343, 732\u2013734 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201594_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","volume":"243","author":"O Gross","year":"2011","unstructured":"Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunol. Rev. 243, 136\u2013151 (2011).","journal-title":"Immunol. Rev."},{"key":"BFnrgastro201594_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis, B. K., Wen, H. & Ting, J. P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707\u2013735 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrgastro201594_CR36","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/art.24959","volume":"60","author":"M Guma","year":"2009","unstructured":"Guma, M. et al. Caspase 1-independent activation of interleukin-1\u03b2 in neutrophil-predominant inflammation. Arthritis Rheum. 60, 3642\u20133650 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro201594_CR37","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.25006","volume":"60","author":"LA Joosten","year":"2009","unstructured":"Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1\u03b2. Arthritis Rheum. 60, 3651\u20133662 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro201594_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","volume":"130","author":"FR Greten","year":"2007","unstructured":"Greten, F. R. et al. NF-\u03baB is a negative regulator of IL-1\u03b2 secretion as revealed by genetic and pharmacological inhibition of IKK\u03b2. Cell 130, 918\u2013931 (2007).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR39","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","volume":"184","author":"KD Mayer-Barber","year":"2010","unstructured":"Mayer-Barber, K. D. et al. Caspase-1 independent IL-1\u03b2 production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326\u20133330 (2010).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR40","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.158.4.1818","volume":"158","author":"G Fantuzzi","year":"1997","unstructured":"Fantuzzi, G. et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J. Immunol. 158, 1818\u20131824 (1997).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR41","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","volume":"96","author":"C Coeshott","year":"1999","unstructured":"Coeshott, C. et al. Converting enzyme-independent release of tumor necrosis factor \u03b1 and IL-1\u03b2 from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl Acad. Sci. USA 96, 6261\u20136266 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR42","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","volume":"341","author":"N Kayagaki","year":"2013","unstructured":"Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246\u20131249 (2013).","journal-title":"Science"},{"key":"BFnrgastro201594_CR43","first-page":"483","volume":"11","author":"CA Dinarello","year":"2000","unstructured":"Dinarello, C. A. Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. 11, 483\u2013486 (2000).","journal-title":"Eur. Cytokine Netw."},{"key":"BFnrgastro201594_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR45","first-page":"305","volume":"119","author":"AB Imaeda","year":"2009","unstructured":"Imaeda, A. B. et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305\u2013314 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2014.03.046","volume":"147","author":"E Serti","year":"2014","unstructured":"Serti, E. et al. Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication. Gastroenterology 147, 209\u2013220 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR47","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/j.1478-3231.2012.02802.x","volume":"32","author":"MI Arshad","year":"2012","unstructured":"Arshad, M. I., Piquet-Pellorce, C. & Samson, M. IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver Int. 32, 1200\u20131210 (2012).","journal-title":"Liver Int."},{"key":"BFnrgastro201594_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coi.2014.03.004","volume":"28","author":"DO Villarreal","year":"2014","unstructured":"Villarreal, D. O. & Weiner, D. B. Interleukin 33: a switch-hitting cytokine. Curr. Opin. Immunol. 28, 102\u2013106 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrgastro201594_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA 104, 282\u2013287 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479\u2013490 (2005).","journal-title":"Immunity"},{"key":"BFnrgastro201594_CR51","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021\u20139026 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4049\/jimmunol.1200259","volume":"189","author":"IG Luzina","year":"2012","unstructured":"Luzina, I. G. et al. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J. Immunol. 189, 403\u2013410 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","volume":"56","author":"V Volarevic","year":"2012","unstructured":"Volarevic, V. et al. Protective role of IL-33\/ST2 axis in Con A-induced hepatitis. J. Hepatol. 56, 26\u201333 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR54","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","volume":"14","author":"P Marvie","year":"2010","unstructured":"Marvie, P. et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell. Mol. Med. 14, 1726\u20131739 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrgastro201594_CR55","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbrc.2006.10.166","volume":"351","author":"H Yin","year":"2006","unstructured":"Yin, H. et al. Pretreatment with soluble ST2 reduces warm hepatic ischemia\/reperfusion injury. Biochem. Biophys. Res. Commun. 351, 940\u2013946 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrgastro201594_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1189\/jlb.1006625","volume":"82","author":"A Amatucci","year":"2007","unstructured":"Amatucci, A. et al. Recombinant ST2 boosts hepatic Th2 response in vivo. J. Leukoc. Biol. 82, 124\u2013132 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro201594_CR57","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","volume":"107","author":"K Oboki","year":"2010","unstructured":"Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl Acad. Sci. USA 107, 18581\u201318586 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296\u2013300 (2010).","journal-title":"Science"},{"key":"BFnrgastro201594_CR59","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/liv.12537","volume":"34","author":"T Csak","year":"2014","unstructured":"Csak, T. et al. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. Liver Int. 34, 1402\u20131413 (2014).","journal-title":"Liver Int."},{"key":"BFnrgastro201594_CR60","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind, F. G. et al. Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787\u2013791 (2009).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR62","doi-asserted-by":"publisher","first-page":"20388","DOI":"10.1073\/pnas.0908698106","volume":"106","author":"SS Iyer","year":"2009","unstructured":"Iyer, S. S. et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl Acad. Sci. USA 106, 20388\u201320393 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","volume":"22","author":"E Latz","year":"2010","unstructured":"Latz, E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 22, 28\u201333 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrgastro201594_CR64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1194\/jlr.M053785","volume":"56","author":"GN Ioannou","year":"2014","unstructured":"Ioannou, G. N. et al. Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. J. Lipid Res. 56, 277\u2013285 (2014).","journal-title":"J. Lipid Res."},{"key":"BFnrgastro201594_CR65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR67","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/febs.13123","volume":"282","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y., Kim, S. J. & Lee, S. M. Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia\/reperfusion. FEBS J. 282, 259\u2013270 (2014).","journal-title":"FEBS J."},{"key":"BFnrgastro201594_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature06664","volume":"452","author":"DA Muruve","year":"2008","unstructured":"Muruve, D. A. et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103\u2013107 (2008).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR69","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514\u2013518 (2009).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR70","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222\u2013230 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ni.1864","volume":"11","author":"VA Rathinam","year":"2010","unstructured":"Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395\u2013402 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni.1824","volume":"11","author":"H Poeck","year":"2010","unstructured":"Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 \u03b2 production. Nat. Immunol. 11, 63\u201369 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhep.2014.08.027","volume":"62","author":"B Lozano-Ruiz","year":"2015","unstructured":"Lozano-Ruiz, B. et al. Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis. J. Hepatol. 62, 64\u201371 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0014-5793(02)03416-6","volume":"530","author":"JM Grenier","year":"2002","unstructured":"Grenier, J. M. et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett. 530, 73\u201378 (2002).","journal-title":"FEBS Lett."},{"key":"BFnrgastro201594_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature11250","volume":"488","author":"PK Anand","year":"2012","unstructured":"Anand, P. K. et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR76","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.4049\/jimmunol.1100412","volume":"186","author":"GY Chen","year":"2011","unstructured":"Chen, G. Y., Liu, M., Wang, F., Bertin, J. & Nunez, G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187\u20137194 (2011).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR77","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","volume":"145","author":"E Elinav","year":"2011","unstructured":"Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745\u2013757 (2011).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR78","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1073\/pnas.1100981108","volume":"108","author":"S Normand","year":"2011","unstructured":"Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl Acad. Sci. USA 108, 9601\u20139606 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.201344135","volume":"44","author":"GY Chen","year":"2014","unstructured":"Chen, G. Y. Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis. Eur. J. Immunol. 44, 321\u2013327 (2014).","journal-title":"Eur. J. Immunol."},{"key":"BFnrgastro201594_CR80","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cell.2014.01.026","volume":"156","author":"M Wlodarska","year":"2014","unstructured":"Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045\u20131059 (2014).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR81","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O'Shea","year":"2010","unstructured":"O'Shea, R. S., Dasarathy, S., McCullough, A. J., Practice Guideline Committee of the American Association for the Study of Liver, D. & Practice Parameters Committee of the American College of, G. Alcoholic liver disease. Hepatology 51, 307\u2013328 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR82","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","volume":"50","author":"P Mandrekar","year":"2009","unstructured":"Mandrekar, P. & Szabo, G. Signalling pathways in alcohol-induced liver inflammation. J. Hepatol. 50, 1258\u20131266 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR83","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.yexmp.2014.08.006","volume":"97","author":"Y Peng","year":"2014","unstructured":"Peng, Y., French, B. A., Tillman, B., Morgan, T. R. & French, S. W. The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp. Mol. Pathol. 97, 305\u2013313 (2014).","journal-title":"Exp. Mol. Pathol."},{"key":"BFnrgastro201594_CR84","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/0024-3205(86)90554-0","volume":"39","author":"CJ McClain","year":"1986","unstructured":"McClain, C. J. et al. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci. 39, 1479\u20131485 (1986).","journal-title":"Life Sci."},{"key":"BFnrgastro201594_CR85","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572\u20131585 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijbiomac.2014.05.034","volume":"69","author":"J Xiao","year":"2014","unstructured":"Xiao, J. et al. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int. J. Biol. Macromol. 69, 73\u201378 (2014).","journal-title":"Int. J. Biol. Macromol."},{"key":"BFnrgastro201594_CR87","first-page":"291","volume":"29","author":"DL Clemens","year":"2006","unstructured":"Clemens, D. L. Use of cultured cells to study alcohol metabolism. Alcohol Res. Health 29, 291\u2013295 (2006).","journal-title":"Alcohol Res. Health"},{"key":"BFnrgastro201594_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo, G. Gut\u2013liver axis in alcoholic liver disease. Gastroenterology 148, 30\u201336 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR89","first-page":"1509","volume":"35","author":"S Inokuchi","year":"2011","unstructured":"Inokuchi, S. et al. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin. Exp. Res. 35, 1509\u20131518 (2011).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"BFnrgastro201594_CR90","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1053\/gast.2002.33613","volume":"122","author":"JB Hoek","year":"2002","unstructured":"Hoek, J. B., Cahill, A. & Pastorino, J. G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122, 2049\u20132063 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR91","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1172\/JCI104643","volume":"41","author":"CS Lieber","year":"1962","unstructured":"Lieber, C. S., Jones, D. P., Losowsky, M. S. & Davidson, C. S. Interrelation of uric acid and ethanol metabolism in man. J. Clin. Invest. 41, 1863\u20131870 (1962).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR92","doi-asserted-by":"publisher","first-page":"e97646","DOI":"10.1371\/journal.pone.0097646","volume":"9","author":"B Stiburkova","year":"2014","unstructured":"Stiburkova, B., Pavlikova, M., Sokolova, J. & Kozich, V. Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS ONE 9, e97646 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR93","doi-asserted-by":"publisher","unstructured":"Petrasek J. et al. Metabolic danger signals, uric acid and ATP mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J. Leukoc. Biol. http:\/\/dx.doi.org\/10.1189\/jlb.3AB1214-590R .","DOI":"10.1189\/jlb.3AB1214-590R"},{"key":"BFnrgastro201594_CR94","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(24)39232-8","volume":"293","author":"H Kono","year":"2000","unstructured":"Kono, H. et al. Allopurinol prevents early alcohol-induced liver injury in rats. J. Pharmacol. Exp. Ther. 293, 296\u2013303 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrgastro201594_CR95","doi-asserted-by":"publisher","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","volume":"289","author":"X Ge","year":"2014","unstructured":"Ge, X. et al. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J. Biol. Chem. 289, 22672\u201322691 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201594_CR96","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu, M. et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174\u2013179 (2006).","journal-title":"Shock"},{"key":"BFnrgastro201594_CR97","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/cdd.2014.40","volume":"21","author":"J Xu","year":"2014","unstructured":"Xu, J. et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ. 21, 1229\u20131239 (2014).","journal-title":"Cell Death Differ."},{"key":"BFnrgastro201594_CR98","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12072-013-9468-6","volume":"7","author":"M Ganz","year":"2013","unstructured":"Ganz, M. & Szabo, G. Immune and inflammatory pathways in NASH. Hepatol. Int. 7, 771\u2013781 (2013).","journal-title":"Hepatol. Int."},{"key":"BFnrgastro201594_CR99","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000360495","volume":"32","author":"WZ Mehal","year":"2014","unstructured":"Mehal, W. Z. The inflammasome in liver injury and non-alcoholic fatty liver disease. Dig. Dis. 32, 507\u2013515 (2014).","journal-title":"Dig. Dis."},{"key":"BFnrgastro201594_CR100","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/cr.2012.55","volume":"22","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi, M. & Kanneganti, T. D. The inflammasome: a remote control for metabolic syndrome. Cell Res. 22, 1095\u20131098 (2012).","journal-title":"Cell Res."},{"key":"BFnrgastro201594_CR101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J. & Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 141\u2013150 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrgastro201594_CR102","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee, H. M. et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62, 194\u2013204 (2013).","journal-title":"Diabetes"},{"key":"BFnrgastro201594_CR103","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR104","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","volume":"20","author":"M Ganz","year":"2014","unstructured":"Ganz, M., Csak, T. & Szabo, G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J. Gastroenterol. 20, 8525\u20138534 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201594_CR105","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898\u2013910 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR106","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","volume":"92","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J. Mol. Med. (Berl.) 92, 1069\u20131082 (2014).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrgastro201594_CR107","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrgastro.2013.146","volume":"10","author":"WZ Mehal","year":"2013","unstructured":"Mehal, W. Z. The Gordian Knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 637\u2013644 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201594_CR108","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","volume":"6","author":"JJ Pan","year":"2014","unstructured":"Pan, J. J. & Fallon, M. B. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol. 6, 274\u2013283 (2014).","journal-title":"World J. Hepatol."},{"key":"BFnrgastro201594_CR109","doi-asserted-by":"publisher","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","volume":"300","author":"T Csak","year":"2011","unstructured":"Csak, T. et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G433\u2013G441 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201594_CR110","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jgh.12020","volume":"28","author":"J Petrasek","year":"2013","unstructured":"Petrasek, J., Csak, T., Ganz, M. & Szabo, G. Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 28, 93\u201398 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201594_CR111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina, J. P. et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61, 77\u201387 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR112","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1189\/jlb.4MR0314-141R","volume":"96","author":"B Saha","year":"2014","unstructured":"Saha, B. & Szabo, G. Innate immune cell networking in hepatitis C virus infection. J. Leukoc. Biol. 96, 757\u2013766 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro201594_CR113","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jhep.2012.10.005","volume":"58","author":"MH Heim","year":"2013","unstructured":"Heim, M. H. Innate immunity and HCV. J. Hepatol. 58, 564\u2013574 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR114","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1053\/j.gastro.2007.08.003","volume":"133","author":"A Dolganiuc","year":"2007","unstructured":"Dolganiuc, A. et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133, 1627\u20131636 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR115","doi-asserted-by":"publisher","first-page":"e1004082","DOI":"10.1371\/journal.ppat.1004082","volume":"10","author":"MA Chattergoon","year":"2014","unstructured":"Chattergoon, M. A. et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 10, e1004082 (2014).","journal-title":"PLoS Pathog."},{"key":"BFnrgastro201594_CR116","doi-asserted-by":"publisher","first-page":"e84953","DOI":"10.1371\/journal.pone.0084953","volume":"9","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. PLoS ONE 9, e84953 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1099\/vir.0.034033-0","volume":"93","author":"D Burdette","year":"2012","unstructured":"Burdette, D. et al. Hepatitis C virus activates interleukin-1\u03b2 via caspase-1-inflammasome complex. J. Gen. Virol. 93, 235\u2013246 (2012).","journal-title":"J. Gen. Virol."},{"key":"BFnrgastro201594_CR118","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","volume":"32","author":"H Jaeschke","year":"2012","unstructured":"Jaeschke, H., Williams, C. D., Ramachandran, A. & Bajt, M. L. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int. 32, 8\u201320 (2012).","journal-title":"Liver Int."},{"key":"BFnrgastro201594_CR119","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","volume":"122","author":"MR McGill","year":"2012","unstructured":"McGill, M. R. et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J. Clin. Invest. 122, 1574\u20131583 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR120","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.27265","volume":"60","author":"MR McGill","year":"2014","unstructured":"McGill, M. R. et al. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 60, 1336\u20131345 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR121","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.taap.2011.10.006","volume":"257","author":"CD Williams","year":"2011","unstructured":"Williams, C. D., Koerner, M. R., Lampe, J. N., Farhood, A. & Jaeschke, H. Mouse strain-dependent caspase activation during acetaminophen hepatotoxicity does not result in apoptosis or modulation of inflammation. Toxicol. Appl. Pharmacol. 257, 449\u2013458 (2011).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnrgastro201594_CR122","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/hep.23940","volume":"53","author":"H Jaeschke","year":"2011","unstructured":"Jaeschke, H., Williams, C. D. & Farhood, A. No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity. Hepatology 53, 718\u2013719 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR123","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.taap.2010.07.004","volume":"247","author":"CD Williams","year":"2010","unstructured":"Williams, C. D., Farhood, A. & Jaeschke, H. Role of caspase-1 and interleukin-1\u03b2 in acetaminophen-induced hepatic inflammation and liver injury. Toxicol. Appl. Pharmacol. 247, 169\u2013178 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnrgastro201594_CR124","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/hep.23022","volume":"49","author":"LE Sander","year":"2009","unstructured":"Sander, L. E. & Blander, J. M. Inflammasome and toll-like receptor 9: Partners in crime in toxic liver injury. Hepatology 49, 2119\u20132121 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR125","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm1603","volume":"13","author":"CJ Chen","year":"2007","unstructured":"Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851\u2013856 (2007).","journal-title":"Nat. Med."},{"key":"BFnrgastro201594_CR126","doi-asserted-by":"publisher","first-page":"G1171","DOI":"10.1152\/ajpgi.00352.2011","volume":"302","author":"R Hoque","year":"2012","unstructured":"Hoque, R. et al. P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1171\u2013G1179 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201594_CR127","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.taap.2011.03.001","volume":"252","author":"CD Williams","year":"2011","unstructured":"Williams, C. D. et al. Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol. Appl. Pharmacol. 252, 289\u2013297 (2011).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnrgastro201594_CR128","doi-asserted-by":"publisher","first-page":"e104741","DOI":"10.1371\/journal.pone.0104741","volume":"9","author":"H Kataoka","year":"2014","unstructured":"Kataoka, H., Kono, H., Patel, Z. & Rock, K. L. Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses. PLoS ONE 9, e104741 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR129","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1172\/JCI40124","volume":"120","author":"H Kono","year":"2010","unstructured":"Kono, H., Chen, C. J., Ontiveros, F. & Rock, K. L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939\u20131949 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201594_CR130","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/hep.26933","volume":"59","author":"CG Antoniades","year":"2014","unstructured":"Antoniades, C. G. et al. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 59, 1564\u20131576 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR131","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.22117","volume":"16","author":"M Abu-Amara","year":"2010","unstructured":"Abu-Amara, M. et al. Liver ischemia\/reperfusion injury: processes in inflammatory networks\u2014a review. Liver Transpl. 16, 1016\u20131032 (2010).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201594_CR132","doi-asserted-by":"publisher","first-page":"176723","DOI":"10.1155\/2012\/176723","volume":"2012","author":"K Weigand","year":"2012","unstructured":"Weigand, K. et al. Ischemia\/Reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg. 2012, 176723 (2012).","journal-title":"HPB Surg."},{"key":"BFnrgastro201594_CR133","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrgastro.2012.225","volume":"10","author":"Y Zhai","year":"2013","unstructured":"Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W. & Kupiec-Weglinski, J. W. Ischaemia\u2013reperfusion injury in liver transplantation\u2014from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 10, 79\u201389 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201594_CR134","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","volume":"26","author":"H Jaeschke","year":"2011","unstructured":"Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J. Gastroenterol. Hepatol. 26, 173\u2013179 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201594_CR135","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1665-2681(19)31415-2","volume":"11","author":"M Gabrielli","year":"2012","unstructured":"Gabrielli, M. et al. Steatotic livers. Can. we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Ann. Hepatol. 11, 891\u2013898 (2012).","journal-title":"Ann. Hepatol."},{"key":"BFnrgastro201594_CR136","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ar.20715","volume":"291","author":"GC Farrell","year":"2008","unstructured":"Farrell, G. C., Teoh, N. C. & McCuskey, R. S. Hepatic microcirculation in fatty liver disease. Anat. Rec. (Hoboken) 291, 684\u2013692 (2008).","journal-title":"Anat. Rec. (Hoboken)"},{"key":"BFnrgastro201594_CR137","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jss.2014.10.024","volume":"194","author":"BJ DuBray Jr.","year":"2014","unstructured":"DuBray, B. J. Jr. et al. BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury. J. Surg. Res. 194, 653\u2013658 (2014).","journal-title":"J. Surg. Res."},{"key":"BFnrgastro201594_CR138","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/hum.2010.145","volume":"22","author":"P Zhu","year":"2011","unstructured":"Zhu, P. et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum. Gene Ther. 22, 853\u2013864 (2011).","journal-title":"Hum. Gene Ther."},{"key":"BFnrgastro201594_CR139","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.4049\/jimmunol.1202733","volume":"191","author":"H Huang","year":"2013","unstructured":"Huang, H. et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 191, 2665\u20132679 (2013).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR140","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/hep.26320","volume":"58","author":"N Kamo","year":"2013","unstructured":"Kamo, N. et al. ASC\/caspase-1\/IL-1\u03b2 signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia\/reperfusion injury. Hepatology 58, 351\u2013362 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR141","first-page":"G949","volume":"271","author":"S Shimizu","year":"1996","unstructured":"Shimizu, S. et al. Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am. J. Physiol. 271, G949\u2013G958 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro201594_CR142","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00007890-199701150-00026","volume":"63","author":"M Shito","year":"1997","unstructured":"Shito, M. et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63, 143\u2013148 (1997).","journal-title":"Transplantation"},{"key":"BFnrgastro201594_CR143","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1097\/00007890-200211270-00016","volume":"74","author":"H Harada","year":"2002","unstructured":"Harada, H. et al. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury. Transplantation 74, 1434\u20131441 (2002).","journal-title":"Transplantation"},{"key":"BFnrgastro201594_CR144","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/hep.20117","volume":"39","author":"D Takeuchi","year":"2004","unstructured":"Takeuchi, D. et al. Interleukin 18 causes hepatic ischemia\/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 39, 699\u2013710 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR145","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.4049\/jimmunol.1302039","volume":"192","author":"Y Inoue","year":"2014","unstructured":"Inoue, Y. et al. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes. J. Immunol. 192, 4342\u20134351 (2014).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR146","doi-asserted-by":"publisher","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","volume":"296","author":"A Watanabe","year":"2009","unstructured":"Watanabe, A. et al. Inflammasome-mediated regulation of hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1248\u2013G1257 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201594_CR147","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.bbadis.2013.03.020","volume":"1832","author":"X Ouyang","year":"2013","unstructured":"Ouyang, X., Ghani, A. & Mehal, W. Z. Inflammasome biology in fibrogenesis. Biochim. Biophys. Acta 1832, 979\u2013988 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrgastro201594_CR148","first-page":"344","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen, R. & Tacke, F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg. Nutr. 3, 344\u2013363 (2014).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"BFnrgastro201594_CR149","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki, E. et al. TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat. Med. 13, 1324\u20131332 (2007).","journal-title":"Nat. Med."},{"key":"BFnrgastro201594_CR150","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/jir.2007.0123","volume":"28","author":"F Khan","year":"2008","unstructured":"Khan, F., Peltekian, K. M. & Peterson, T. C. Effect of interferon-\u03b1, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation. J. Interferon Cytokine Res. 28, 643\u2013651 (2008).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrgastro201594_CR151","doi-asserted-by":"publisher","first-page":"G1324","DOI":"10.1152\/ajpgi.90564.2008","volume":"296","author":"RG Gieling","year":"2009","unstructured":"Gieling, R. G., Wallace, K. & Han, Y. P. Interleukin-1 participates in the progression from liver injury to fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1324\u2013G1331 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201594_CR152","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/pmic.200800761","volume":"9","author":"B de Roos","year":"2009","unstructured":"de Roos, B. et al. Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9, 3244\u20133256 (2009).","journal-title":"Proteomics"},{"key":"BFnrgastro201594_CR153","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","volume":"55","author":"Y Kamari","year":"2011","unstructured":"Kamari, Y. et al. Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J. Hepatol. 55, 1086\u20131094 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR154","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1074\/jbc.M412220200","volume":"280","author":"K Isoda","year":"2005","unstructured":"Isoda, K. et al. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J. Biol. Chem. 280, 7002\u20137009 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201594_CR155","doi-asserted-by":"publisher","first-page":"e56100","DOI":"10.1371\/journal.pone.0056100","volume":"8","author":"LJ Dixon","year":"2013","unstructured":"Dixon, L. J., Flask, C. A., Papouchado, B. G., Feldstein, A. E. & Nagy, L. E. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS ONE 8, e56100 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR156","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","volume":"192","author":"EO Samstad","year":"2014","unstructured":"Samstad, E. O. et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. 192, 2837\u20132845 (2014).","journal-title":"J. Immunol."},{"key":"BFnrgastro201594_CR157","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2228","volume":"13","author":"H Wen","year":"2012","unstructured":"Wen, H., Ting, J. P. & O'Neill, L. A. A role for the NLRP3 inflammasome in metabolic diseases\u2014did Warburg miss inflammation? Nat. Immunol. 13, 352\u2013357 (2012).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro201594_CR158","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.3748\/wjg.v17.i43.4772","volume":"17","author":"M Ganz","year":"2011","unstructured":"Ganz, M., Csak, T., Nath, B. & Szabo, G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J. Gastroenterol. 17, 4772\u20134778 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201594_CR159","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210\u2013215 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201594_CR160","doi-asserted-by":"publisher","first-page":"16544","DOI":"10.1073\/pnas.1308331110","volume":"110","author":"J Petrasek","year":"2013","unstructured":"Petrasek, J. et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl Acad. Sci. USA 110, 16544\u201316549 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201594_CR161","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.alcohol.2008.03.131","volume":"42","author":"V Purohit","year":"2008","unstructured":"Purohit, V. et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42, 349\u2013361 (2008).","journal-title":"Alcohol"},{"key":"BFnrgastro201594_CR162","doi-asserted-by":"publisher","first-page":"251S","DOI":"10.1111\/j.1530-0277.2001.tb02404.x","volume":"25","author":"MG Neuman","year":"2001","unstructured":"Neuman, M. G. et al. Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin. Exp. Res. 25, 251S\u2013253S (2001).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"BFnrgastro201594_CR163","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.gastro.2010.04.041","volume":"139","author":"JI Cohen","year":"2010","unstructured":"Cohen, J. I., Roychowdhury, S., McMullen, M. R., Stavitsky, A. B. & Nagy, L. E. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139, 664\u2013674 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR164","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/hep.22776","volume":"49","author":"S Roychowdhury","year":"2009","unstructured":"Roychowdhury, S. et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49, 1326\u20131334 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR165","first-page":"683","volume":"149","author":"S Sherlock","year":"1988","unstructured":"Sherlock, S. Liver disease in women. Alcohol, autoimmunity, and gallstones. West. J. Med. 149, 683\u2013686 (1988).","journal-title":"West. J. Med."},{"key":"BFnrgastro201594_CR166","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/01.ALC.0000128229.23396.42","volume":"28","author":"S Stranges","year":"2004","unstructured":"Stranges, S. et al. Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol Clin. Exp. Res. 28, 949\u2013956 (2004).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"BFnrgastro201594_CR167","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1360-0443.2008.02493.x","volume":"104","author":"J Hatton","year":"2009","unstructured":"Hatton, J. et al. Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease. Addiction 104, 587\u2013592 (2009).","journal-title":"Addiction"},{"key":"BFnrgastro201594_CR168","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2014.12.005","volume":"62","author":"G Askgaard","year":"2015","unstructured":"Askgaard, G. et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J. Hepatol. 62, 1061\u20131067 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201594_CR169","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/hep.24301","volume":"53","author":"T Csak","year":"2011","unstructured":"Csak, T. et al. Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 53, 1917\u20131931 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR170","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"Kohli, R. et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934\u2013944 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR171","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201594_CR172","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836\u20131846 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR173","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1021\/jm050307e","volume":"48","author":"SD Linton","year":"2005","unstructured":"Linton, S. D. et al. First-in-class pan caspase inhibitor developed for the treatment of liver disease. J. Med. Chem. 48, 6779\u20136782 (2005).","journal-title":"J. Med. Chem."},{"key":"BFnrgastro201594_CR174","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2010.04264.x","volume":"31","author":"ML Shiffman","year":"2010","unstructured":"Shiffman, M. L. et al. Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor\u2014a randomized placebo-controlled study in patients with chronic hepatitis, C. Aliment. Pharmacol. Ther. 31, 969\u2013978 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201594_CR175","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-6143.2006.01595.x","volume":"7","author":"ES Baskin-Bey","year":"2007","unstructured":"Baskin-Bey, E. S. et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am. J. Transplant 7, 218\u2013225 (2007).","journal-title":"Am. J. Transplant"},{"key":"BFnrgastro201594_CR176","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/hep.21664","volume":"46","author":"PJ Pockros","year":"2007","unstructured":"Pockros, P. J. et al. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis, C. Hepatology 46, 324\u2013329 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR177","first-page":"568","volume":"13","author":"SH MacKenzie","year":"2010","unstructured":"MacKenzie, S. H., Schipper, J. L. & Clark, A. C. The potential for caspases in drug discovery. Curr. Opin. Drug Discov. Devel. 13, 568\u2013576 (2010).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"BFnrgastro201594_CR178","first-page":"81","volume":"11","author":"LD Church","year":"2009","unstructured":"Church, L. D. & McDermott, M. F. Canakinumab, a fully-human mAb against IL-1\u03b2 for the potential treatment of inflammatory disorders. Curr. Opin. Mol. Ther. 11, 81\u201389 (2009).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"BFnrgastro201594_CR179","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2014)."},{"key":"BFnrgastro201594_CR180","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrendo.2009.271","volume":"6","author":"T Mandrup-Poulsen","year":"2010","unstructured":"Mandrup-Poulsen, T., Pickersgill, L. & Donath, M. Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 6, 158\u2013166 (2010).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrgastro201594_CR181","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1475-2840-13-94","volume":"13","author":"C Howard","year":"2014","unstructured":"Howard, C. et al. Safety and tolerability of canakinumab, an IL-1\u03b2 inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies. Cardiovasc. Diabetol. 13, 94 (2014).","journal-title":"Cardiovasc. Diabetol."},{"key":"BFnrgastro201594_CR182","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.cdd.4402034","volume":"14","author":"BA Callus","year":"2007","unstructured":"Callus, B. A. & Vaux, D. L. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 14, 73\u201378 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnrgastro201594_CR183","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. J. Cell Biol. 187, 61\u201370 (2009).","journal-title":"J. Cell Biol."},{"key":"BFnrgastro201594_CR184","doi-asserted-by":"publisher","first-page":"e93058","DOI":"10.1371\/journal.pone.0093058","volume":"9","author":"A Bhaskaracharya","year":"2014","unstructured":"Bhaskaracharya, A. et al. Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE 9, e93058 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR185","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.metabol.2014.02.003","volume":"63","author":"SJ Yang","year":"2014","unstructured":"Yang, S. J. & Lim, Y. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 63, 693\u2013701 (2014).","journal-title":"Metabolism"},{"key":"BFnrgastro201594_CR186","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/hep.24802","volume":"55","author":"A Ambade","year":"2012","unstructured":"Ambade, A., Catalano, D., Lim, A. & Mandrekar, P. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology 55, 1585\u20131595 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro201594_CR187","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR188","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nature11419","volume":"490","author":"P Broz","year":"2012","unstructured":"Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288\u2013291 (2012).","journal-title":"Nature"},{"key":"BFnrgastro201594_CR189","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3109\/00365528309182111","volume":"18","author":"P Staun-Olsen","year":"1983","unstructured":"Staun-Olsen, P., Bjorneboe, M., Prytz, H., Thomsen, A. C. & Orskov, F. Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum IgA. Scand. J. Gastroenterol. 18, 889\u2013896 (1983).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201594_CR190","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-405211-6.00006-1","volume":"59","author":"J Petrasek","year":"2013","unstructured":"Petrasek, J., Csak, T. & Szabo, G. Toll-like receptors in liver disease. Adv. Clin. Chem. 59, 155\u2013201 (2013).","journal-title":"Adv. Clin. Chem."},{"key":"BFnrgastro201594_CR191","doi-asserted-by":"publisher","first-page":"e96864","DOI":"10.1371\/journal.pone.0096864","volume":"9","author":"S Bala","year":"2014","unstructured":"Bala, S., Marcos, M., Gattu, A., Catalano, D. & Szabo, G. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS ONE 9, e96864 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201594_CR192","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.intimp.2013.10.025","volume":"18","author":"C Bode","year":"2014","unstructured":"Bode, C. et al. Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro. Int. Immunopharmacol. 18, 27\u201334 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"BFnrgastro201594_CR193","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0092-8674(95)90490-5","volume":"80","author":"P Li","year":"1995","unstructured":"Li, P. et al. Mice deficient in IL-1 \u03b2-converting enzyme are defective in production of mature IL-1 \u03b2 and resistant to endotoxic shock. Cell 80, 401\u2013411 (1995).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR194","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0092-8674(00)80943-5","volume":"92","author":"S Wang","year":"1998","unstructured":"Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501\u2013509 (1998).","journal-title":"Cell"},{"key":"BFnrgastro201594_CR195","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/1354750X.2014.897757","volume":"19","author":"MR McGill","year":"2014","unstructured":"McGill, M. R. et al. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 19, 222\u2013230 (2014).","journal-title":"Biomarkers"},{"key":"BFnrgastro201594_CR196","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.taap.2014.01.004","volume":"275","author":"CD Williams","year":"2014","unstructured":"Williams, C. D. et al. Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol. Appl. Pharmacol. 275, 122\u2013133 (2014).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFnrgastro201594_CR197","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00204-013-1118-1","volume":"88","author":"MR McGill","year":"2014","unstructured":"McGill, M. R. et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch. Toxicol. 88, 391\u2013401 (2014).","journal-title":"Arch. Toxicol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.94.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.94","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.94.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:30:23Z","timestamp":1748421023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":197,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFnrgastro201594"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.94","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,9]]},"assertion":[{"value":"9 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}